Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

MMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas

Oncogene volume 36, pages 2275–2285 (2017)Cite this article

Subjects

Abstract

Metaplastic breast carcinoma is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (EMT). However, the defining molecular events are unknown. Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma. We generated a mouse model of mammary epithelial-specific Ccn6 deletion by developing a floxed Ccn6 mouse which was bred with an MMTV-Cre mouse. Ccn6fl/fl;MMTV-Cre mice displayed severe defects in ductal branching and abnormal age-related involution compared to littermate controls. Ccn6fl/fl;MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide EMT, histologically similar to human metaplastic breast carcinomas. Global gene expression profiling of Ccn6fl/fl mammary carcinomas and comparison of orthologous genes with a human metaplastic carcinoma signature revealed a significant overlap of 87 genes (P=5 × 10−11). Among the shared deregulated genes between mouse and human are important regulators of epithelial morphogenesis including Cdh1, Ck19, Cldn3 and 4, Ddr1, and Wnt10a. These results document a causal role for Ccn6 deletion in the pathogenesis of metaplastic carcinomas with histological and molecular similarities with human disease. We provide a platform to study new targets in the diagnosis and treatment of human metaplastic carcinomas, and a new disease relevant model in which to test new treatment strategies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Oberman HA . Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol 1987; 11: 918–929.

    Article  CAS  PubMed  Google Scholar 

  2. Bae SY, Lee SK, Koo MY, Hur SM, Choi MY, Cho DH et al. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients. Breast Cancer Res Treat 2011; 126: 471–478.

    Article  CAS  PubMed  Google Scholar 

  3. Luini A, Aguilar M, Gatti G, Fasani R, Botteri E, Brito JA et al. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat 2007; 101: 349–353.

    Article  PubMed  Google Scholar 

  4. Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA et al. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res 2015; 21: 1688–1698.

    Article  CAS  PubMed  Google Scholar 

  5. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 2009; 69: 4116–4124.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Weigelt B, Ng CK, Shen R, Popova T, Schizas M, Natrajan R et al. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected]. Mod Pathol 2015; 28: 340–351.

    Article  CAS  PubMed  Google Scholar 

  7. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007; 213: 374–383.

    Article  CAS  PubMed  Google Scholar 

  8. Jun JI, Lau LF . Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 2011; 10: 945–963.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Huang W, Zhang Y, Varambally S, Chinnaiyan AM, Banerjee M, Merajver SD et al. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1. Am J Pathol 2008; 172: 893–904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lau LF . CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci 2011; 68: 3149–3163.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lorenzatti G, Huang W, Pal A, Cabanillas AM, Kleer CG . CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer. J Cell Sci 2011; 124: 1752–1758.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Pal A, Huang W, Li X, Toy KA, Nikolovska-Coleska Z, Kleer CG . CCN6 modulates BMP signaling via the Smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer. Cancer Res 2012a; 72: 4818–4828.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zhang Y, Pan Q, Zhong H, Merajver SD, Kleer CG. . Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Res 2005; 7: R1080–R1089.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kleer CG, Zhang Y, Pan Q, Merajver SD . WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. Neoplasia 2004; 6: 179–185.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. van Golen KL, Davies S, Wu ZF, Wang YF, Bucana CD, Root H et al. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 1999; 5: 2511–2519.

    CAS  PubMed  Google Scholar 

  16. Huang W, Gonzalez ME, Toy KA, Banerjee M, Kleer CG . Blockade of CCN6 (WISP3) activates growth factor-independent survival and resistance to anoikis in human mammary epithelial cells. Cancer Res 2010; 70: 3340–3350.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Pal A, Huang W, Toy KA, Kleer CG . CCN6 knockdown disrupts acinar organization of breast cells in three-dimensional cultures through up-regulation of type III TGF-beta receptor. Neoplasia 2012b; 14: 1067–1074.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD et al. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 2006; 98: 1600–1607.

    Article  PubMed  Google Scholar 

  19. Radisky DC, Hartmann LC . Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia 2009; 14: 181–191.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Guy CT, Cardiff RD, Muller WJ . Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992; 12: 954–961.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Koker MM, Kleer CG . p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol 2004; 28: 1506–1512.

    Article  PubMed  Google Scholar 

  22. Rakha EA, Tan PH, Varga Z, Tse GM, Shaaban AM, Climent F et al. Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. Br J Cancer 2015; 112: 283–289.

    Article  CAS  PubMed  Google Scholar 

  23. Reis-Filho JS, Milanezi F, Carvalho S, Simpson PT, Steele D, Savage K et al. Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis. Breast Cancer Res 2005; 7: R1028–R1035.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Rungta S, Kleer CG . Metaplastic carcinomas of the breast: diagnostic challenges and new translational insights. Arch Pathol Lab Med 2012; 136: 896–900.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Reis-Filho JS, Milanezi F, Paredes J, Silva P, Pereira EM, Maeda SA et al. Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol 2003; 11: 1–8.

    CAS  PubMed  Google Scholar 

  26. Reis-Filho JS, Schmitt FC . p63 expression in sarcomatoid/metaplastic carcinomas of the breast. Histopathology 2003; 42: 94–95.

    Article  CAS  PubMed  Google Scholar 

  27. Hennessy BT, Giordano S, Broglio K, Duan Z, Trent J, Buchholz TA et al. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol 2006; 17: 605–613.

    Article  CAS  PubMed  Google Scholar 

  28. Hayes MJ, Thomas D, Emmons A, Giordano TJ, Kleer CG . Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast. Clin Cancer Res 2008; 14: 4038–4044.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Anwar TE, Kleer CG . Tissue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancer. Hum Pathol 2013; 44: 1457–1464.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Hurvitz JR, Suwairi WM, Van Hul W, El-Shanti H, Superti-Furga A, Roudier J et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet 1999; 23: 94–98.

    Article  CAS  PubMed  Google Scholar 

  31. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J et al. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 1998; 95: 14717–14722.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kutz WE, Gong Y, Warman ML . WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice. Mol Cell Biol 2005; 25: 414–421.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Huang W, Martin EE, Burman B, Gonzalez ME, Kleer CG . The matricellular protein ccn6 (wisp3) decreases notch1 and suppresses breast cancer initiating cells. Oncotarget 2016; 7: 25180–25193.

    PubMed  PubMed Central  Google Scholar 

  34. Kleer CG, Zhang Y, Pan Q, van Golen KL, Livant D et al. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene 2002; 21: 3172–3180.

    Article  CAS  PubMed  Google Scholar 

  35. Ferguson BW, Gao X, Kil H, Lee J, Benavides F, Abba MC et al. Conditional Wwox deletion in mouse mammary gland by means of two Cre recombinase approaches. PLoS One 2012; 7: e36618.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. McAllister KA, Bennett LM, Houle CD, Ward T, Malphurs J, Collins NK et al. Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene. Cancer Res 2002; 62: 990–994.

    CAS  PubMed  Google Scholar 

  37. Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 1999; 22: 37–43.

    Article  CAS  PubMed  Google Scholar 

  38. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet 1997; 17: 32–39.

    Article  CAS  PubMed  Google Scholar 

  39. Blackburn AC, Hill LZ, Roberts AL, Wang J, Aud D, Jung J et al. Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk. Am J Pathol 2007; 170: 2030–2041.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Tchatchou S, Riedel A, Lyer S, Schmutzhard J, Strobel-Freidekind O, Gronert-Sum S et al. Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity. Hum Mutat 2010; 31: 60–66.

    Article  CAS  PubMed  Google Scholar 

  41. Jones LP, Buelto D, Tago E, Owusu-Boaitey KE . Abnormal mammary adipose tissue environment of Brca1 mutant mice show a persistent deposition of highly vascularized multilocular adipocytes. J Cancer Sci Ther 2011; (Suppl 2)pii 004.

  42. Zhang Y, Toy KA, Kleer CG . Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition. Mod Pathol 2012; 25: 178–184.

    Article  CAS  PubMed  Google Scholar 

  43. Morishita A, Zaidi MR, Mitoro A, Sankarasharma D, Szabolcs M, Okada Y et al. HMGA2 is a driver of tumor metastasis. Cancer Res 2013; 73: 4289–4299.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Li Y, Francia G, Zhang JY . p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer. Oncotarget 2015; 6: 32656–32668.

    PubMed  PubMed Central  Google Scholar 

  45. Zhou ZN, Sharma VP, Beaty BT, Roh-Johnson M, Peterson EA, Van Rooijen N et al. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo. Oncogene 2014; 33: 3784–3793.

    Article  CAS  PubMed  Google Scholar 

  46. Bernardo GM, Keri RA . FOXA1: a transcription factor with parallel functions in development and cancer. Biosci Rep 2012; 32: 113–130.

    Article  CAS  PubMed  Google Scholar 

  47. Parr C, Jiang WG . Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Int J Cancer 2006; 119: 1176–1183.

    Article  CAS  PubMed  Google Scholar 

  48. Toy KA, Valiathan RR, Nunez F, Kidwell KM, Gonzalez ME, Fridman R et al. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer. Breast Cancer Res Treat 2015; 150: 9–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249–264.

    Article  PubMed  Google Scholar 

  50. Smyth GK . Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article3.

    Article  PubMed  Google Scholar 

  51. Ritchie ME, Diyagama D, Neilson J, van Laar R, Dobrovic A, Holloway A et al. Empirical array quality weights in the analysis of microarray data. BMC Bioinform 2006; 7: 261.

    Article  Google Scholar 

  52. Benjamini Y, Hochberg Y . Controlling the false discovery rate: a practical and powerful approach in multiple testing. J R Stat Soc 1995, Series B 57: 289–300.

    Google Scholar 

Download references

Acknowledgements

This work was supported by the National Institutes of Health (NIH) grant R01CA125577 and R01CA107469 (C.G.K), F30CA196084 (T.A), R25GM086262 (PREP program, C.A-G), and the University of Michigan’s Cancer Center Support grant 5 P30 CA46592. We thank Dr Stephen Weiss for the MMTV-Cre line A mice in FVB background, and members of the Kleer lab for critical review of the manuscript.

Author information

Authors and Affiliations

  1. Department of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA

    E E Martin, W Huang, T Anwar, C Arellano-Garcia, B Burman, M E Gonzalez & C G Kleer

  2. Medical Scientist Training Program and Molecular and Cellular Pathology Graduate Program, University of Michigan, Ann Arbor, MI, USA

    T Anwar

  3. Post-baccalaureate Research Education Program, University of Michigan, Ann Arbor, MI, USA

    C Arellano-Garcia

  4. Department of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA

    J-L Guan

Authors
  1. E E Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Anwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Arellano-Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Burman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J-L Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M E Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C G Kleer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C G Kleer.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martin, E., Huang, W., Anwar, T. et al. MMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas. Oncogene 36, 2275–2285 (2017). https://doi.org/10.1038/onc.2016.381

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2016.381

This article is cited by

Search

Advanced search

Quick links